Core Insights - Gelteq Limited has entered a three-year sales agreement with Shenzhen Mana Health Management Co. Ltd. to distribute consumer nutritional products in China, with minimum annual order commitments totaling approximately USD $1.3 million [1][3][5] - The agreement aims to expand Gelteq's nutritional product portfolio in China, leveraging Mana's established distribution network and digital presence [2][4] Company Overview - Gelteq is a biotechnology company based in Melbourne, Australia, specializing in gel-based oral delivery technologies for pharmaceuticals and consumer health products [6] - The company focuses on enhancing bioavailability, improving patient compliance, and enabling precise dosing through its proprietary gel formulation technology [6] Market Strategy - The partnership with Mana is part of Gelteq's strategy to penetrate the rapidly growing wellness and functional nutrition market in China [4][5] - Gelteq plans to introduce additional nutritional products that utilize its proprietary technology as part of this agreement [4] Distribution and Promotion - Mana will promote and sell a nutritional formulation primarily aimed at lowering sugar levels across its multichannel healthcare network in China [3][5] - The agreement is expected to generate predictable revenue and advance the adoption of Gelteq's platform in a strategically important market for nutritional products [5]